FDA-Inspected Site

MolecularMD Corp

2 FDA inspections are on record for MolecularMD Corp in Portland, United States.

483· Form 483 issued

Portland, United States · Last updated August 15, 2026

Overview

  • 2 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2026-05-29.

At a glance

Inspections

2

Form 483s

1

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
18 May 2026 – 29 May 2026Medical Devices & Rad Health483View 483 →
28 Feb 2022 – 2 Mar 2022Medical Devices & Rad HealthClean

Observations on record

Form 483 observations cited at this site, most recent first.

29 May 2026
ISO 13485:2016 Clause 5.6.1

QMS not reviewed by top management at documented planned intervals

Cited by Alexandria L Capuano, Richard E Evoy

29 May 2026
ISO 13485:2016 Clause 7.4.1

Supplier monitoring and re-evaluation not planned

Cited by Alexandria L Capuano, Richard E Evoy

29 May 2026
ISO 13485:2016 Clause 8.2.4

Internal audits not conducted to ensure QMS meets requirements and is effective

Cited by Alexandria L Capuano, Richard E Evoy

Investigators

FDA investigators tied to this site in the record.

Richard E Evoy1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
ISO 13485:2016 Clause 5.6.1Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 7.4.1Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 8.2.4Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind MolecularMD Corp's 1 Form 483

Recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat